Lineage Cell Therapeutics (LCTX) Capital Expenditures (2010 - 2026)
Lineage Cell Therapeutics (LCTX) posted Capital Expenditures of $108,000 for Q2 2026, up 671.4% from $14,000 a year earlier and up 96.4% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Capital Expenditures (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Lineage Cell Therapeutics was $574,000, down 2.4% year-over-year; for FY2025, it came in at $522,000, down 7.6% from FY2024.
- Annual Capital Expenditures shows a five-year compound annual growth rate of 52.2% (FY2020 to FY2025).
- In prior years, Lineage Cell Therapeutics' Capital Expenditures was $565,000 in FY2024 (-16.2%), $674,000 in FY2023 (+63.2%), $413,000 in FY2022 (+21.5%) and $340,000 in FY2021 (+431.3%).
- Quarterly Capital Expenditures has run from a low of -$16,000 in Q4 2022 to a high of $399,000 in Q4 2025 over five years.
- On a year-over-year basis, Capital Expenditures increased in four of the last eight quarters, with growth averaging 114.1%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q2 2026, with growth of 671.4%; the weakest was Q3 2025, with a decline of 89.3%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $55,000 (Q1 2026), $399,000 (Q4 2025) and $12,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Lineage Cell Therapeutics | 240.26 Mn | 38.67 Mn | - | 108,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 108,000.00 |
| Mar 31, 2026 | 55,000.00 |
| Dec 31, 2025 | 399,000.00 |
| Sep 30, 2025 | 12,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Mar 31, 2025 | 97,000.00 |
| Dec 31, 2024 | 365,000.00 |
| Sep 30, 2024 | 112,000.00 |
| Jun 30, 2024 | 50,000.00 |
| Mar 31, 2024 | 38,000.00 |
| Dec 31, 2023 | 91,000.00 |
| Sep 30, 2023 | 139,000.00 |
| Jun 30, 2023 | 256,000.00 |
| Mar 31, 2023 | 188,000.00 |
| Dec 31, 2022 | -16,000.00 |
| Sep 30, 2022 | 286,000.00 |
| Jun 30, 2022 | 97,000.00 |
| Mar 31, 2022 | 46,000.00 |
| Dec 31, 2021 | 146,000.00 |
| Sep 30, 2021 | 54,000.00 |
API Access
Lineage Cell Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();